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Antiretroviral therapy (ART) has significantly improved immune health and survival rates in 
HIV, but these outcomes rely on near perfect adherence. While many psychosocial factors 
are related to sub-optimal adherence, effectiveness of associated interventions are modest 
or inconsistent. The Psychological Flexibility (PF) model underlying Acceptance and 
Commitment Therapy (ACT) identifies a core set of broadly applicable transdiagnostic 
processes that may be useful to explain and improve non-adherence. However, PF has not 
previously been examined in relation to ART adherence. Therefore, this cross-sectional 
study (n=275) explored relationships between PF and intentional/unintentional ART non-
adherence in people with HIV.  Adults with HIV prescribed ART were recruited online. 
Participants completed online questionnaires assessing self-reported PF, adherence and 
emotional and general functioning. Logistic regressions examined whether PF processes 
were associated with intentional/unintentional non-adherence. Fifty-eight percent of 
participants were classified as nonadherent according to the Medication Adherence Rating 
Scale, of which 41.0% reported intentional and 94.0% unintentional non-adherence. 
Correlations between PF and adherence were small. PF did not significantly explain 
intentional/unintentional non-adherence after controlling for demographic and disease 
factors. Further clarification of the utility of PF in understanding ART non-adherence is 
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The human immunodeficiency virus (HIV) remains a global health concern (UNAIDS, 
2014; WHO, 2014). Antiretroviral therapy (ART) slows disease progression and reduces 
transmission, being widely available in well-resourced countries (Ambrosioni, Calmy, & 
Hirschel, 2011; Ingersoll & Cohen, 2008; Jones, Taylor, Wilkin, & Hammer, 2007). However, 
on average people living with HIV (PLWHIV) only take around 70% of prescribed doses 
(Malta, Strathdee, Magnanini, & Bastos, 2008; Simoni et al., 2006). 
 
Individual, treatment and healthcare provider factors contribute to ART non-adherence 
(García & Côté, 2003). Common ART side-effects (Raines, Radcliffe, & Treisman, 2005) do 
not consistently correlate with non-adherence (Carrieri et al., 2006; Harzke et al., 2004; 
Molassiotis et al., 2002). Rather, studies show a wide range of psychosocial factors share 
small to medium associations with ART non-adherence (Catz, Kelly, Bogart, Benotsch, & 
McAuliffe, 2000; Gonzalez, Batchelder, Psaros, & Safren, 2011; Harzke et al., 2004; Ingersoll 
& Heckman, 2005; Ironson et al., 2005; Katz et al., 2013; Langebeek et al., 2014; Molassiotis 
et al., 2002; Ortego et al., 2011; Uthman, Magidson, Safren, & Nachega, 2014). Most 
variables included in these studies are guided by Social cognitive models (SCM), which 
theorise that non-adherence is driven by intentions and beliefs about illness and treatments 
(Munro, Lewin, Swart, & Volmink, 2007). Growing evidence suggests that such models lack 
explanatory power in predicting ART adherence (Brandes & Mullan, 2014; Horne et al., 




treatment trials aiming to improve adherence also show inconsistent/modest efficacy 
(Binford, Kahana, & Altice, 2012; Chaiyachati et al., 2014; Conn, Ruppar, Enriquez, & Cooper, 
2016). It has been theorised that this is because such models underestimate the impact of 
emotional, behavioural, motivational and wider socio-economic contextual processes on 
adherence (Michie, Van Stralen, & West, 2011). Further, it has been argued that SCMs are 
better placed to explain intentional rather than unintentional non-adherence (i.e. forgetting 
(Lehane & McCarthy, 2007)), where adherence depends on conscious costs-benefit 
expectations/evaluative processes (Edwards, 1954). Although unintentional non-adherence 
could be due to impaired memory, it might also reflect a socially desirable response, change 
in mood, disease and treatment burden or access (Lehane, 2007; Molloy, 2014). Therefore, 
disentangling causes of intentional/unintentional non-adherence may be challenging 
(Gadkari & McHorney, 2012). 
 
The Psychological Flexibility model (PF) (Hayes, Strosahl, & Wilson, 1999) provides an 
alternative behavioural/psychosocial framework to understand ART non-adherence 
stemming from philosophical assumptions and basic theory that are distinct from SCMs 
(Hayes, Barnes-Holmes, & Roche, 2001; Vilardaga, Hayes, & Schelin, 2007). Described as a 
transdiagnostic theory of “normal” human behaviour (McCracken & Morley, 2014), PF 
incorporates emotional, motivational and attentional processes that may be lacking in SCM. 
PF is “the capacity for an individual to persist with, or change, behaviour in a manner that 
includes conscious and open contact with thoughts and feelings, appreciates what situations 
afford, and serves one’s goals and values” (Scott & McCracken, 2015, p.91). PF incorporates 




elements: Acceptance, defusion, self-as-context, present moment awareness, values and 
committed action (Hayes, Luoma, Bond, Masuda, & Lillis, 2006). 
 
Psychological inflexibility could explain intentional and unintentional non-adherence to 
ART. According to Hayes et al.’s (2011) “Open, Aware, and Active/Engaged” facets, PLWHIV 
may lead a person to behavioural patterns that contribute to non-adherence:  
(i) Avoid situations, thoughts, feelings or bodily sensations (“Closed”) to 
reduce/eliminate side-effects or anxiety and/or shameful thoughts and feelings 
related to taking ART. 
(ii) Become overly influenced by difficult thoughts and feelings related to 
ART, unable to take a different perspective (“Unaware”), dwelling on life before 
their diagnosis and worrying about the future. 
(iii) Fail to identify and pursue valued life directions/goals, and instead 
persist in unhelpful behaviour (“Inactive/Disengaged”), such as skipping doses and 
not connecting with how adhering might serve their long-term values/goals (e.g., 
being independent).  
Arguably, experiential avoidance and lack of present moment awareness could occur in and 
outside of conscious awareness. Therefore, PF does not distinguish between 
intentional/unintentional non-adherence. PF assumes that effective action, e.g., being 
adherent, can happen despite difficult thoughts or feelings, low self-efficacy, or 
contradicting illness/treatment beliefs. HIV studies indicate PF is strongly associated with 
better self-reported illness management, mental health and quality of life (Chartier et al., 





Acceptance and Commitment Therapy (ACT) is the treatment approach most directly 
focused on increasing PF (Hayes et al., 2006). Rather than modifying content, frequency or 
intensity of beliefs or feelings typical of traditional cognitive-behaviour therapy and SCM-
informed approaches (Conn et al., 2016; Easthall, Song, & Bhattacharya, 2013), ACT helps to 
decrease their literal influence and set current behaviour against a person’s values to 
encourage a more Open, Aware and Engaged stance (Hayes, Levin, Plumb-Vilardaga, 
Villatte, & Pistorello, 2013). Consequently, clarity of an individual’s informed decisions 
about treatment could be enhanced. For example, willingness to experience side-effects or 
negative thoughts about ART, alongside valued-goals around “being healthy”, may facilitate 
adherence. 
 
Evidence supporting ACT for improved general/social functioning has grown in LTCs 
(Graham, Gouick, Krahé, & Gillanders, 2016; Hann & McCracken, 2014). A small, 
uncontrolled ACT feasibility trial for PLWHIV shows trends towards reductions in viral load 
and increases in CD4+ counts post-treatment (Moitra, Herbert, & Forman, 2011). ACT may 
improve engagement in medical care for newly diagnosed PLWHIV (Moitra, Chan, & Stein, 
2015) and reduce stigma (Skinta, Lezama, Wells, & Dilley, 2014). While one study (Berghoff 
et al., 2018) has identified small relationships between experiential avoidance, non-
adherence and strained patient–provider interactions, few have examined other PF 





1.1. Study aims and hypotheses 
 
 
This study examined the associations between components of PF, self-reported 
adherence and general functioning. Current evidence suggests an interaction between non-
adherence, cognitive impairment, depression and regimen complexity (Hinkin et al., 2002). 
Therefore, examining PF processes in explaining non-adherence and HIV-related 
functioning, independent of these variables is important. The following hypotheses were 
tested: 
 
(i) PF components will be positively associated with adherence, independent of 
demographic and illness characteristics. 
 
(ii) PF components will be positively associated with general functioning. 
 
2. Materials and methods 
 
 
This international cross-sectional survey (Bristol Online Surveys) recruited n=283 PLWHIV 
18+ years of age currently prescribed ART (July 2016-2017). The study was approved by 
Research Ethics Committee King’s College London (August 2016: HR-15/16-2496). Informed 
consent was obtained online. Participants were recruited via online HIV organisations, 
charities, Facebook and Twitter, identified through NAM AIDSMAP e-atlas 




related charities and organisations globally.  Eight cases were excluded (underage (n=1), not 





2.1.1. Self-reported medication adherence measure 
 
 
The Medication Adherence Report Scale (MARS-5) (Horne, Hankins, & Jenkins, 2001) 
measures medication-taking behaviour. The MARS-5 shows good internal reliability and 
test-retest reliability (α=0.83) in other long-term health conditions (LTCs) (Salt, L, Peden, & 
Horne, 2012), despite showing mixed associations with more objective adherence measures 
(Jónsdóttir et al., 2010; Tommelein, Mehuys, Van Tongelen, Brusselle, & Boussery, 2014). It 
has not yet been used with PLWHIV, but unlike other scales distinguishes 
intentional/unintentional non-adherence (Chesney et al., 2000; Morisky, Green, & Levine, 
1986). Adherence was defined as a score of 25 (100%). Unintentional non-adherence 
reflected a subscale-score <5 and intentional non-adherence a subscale-score <20 (de Vries 
et al., 2014; Moon, Moss-Morris, Hunter, & Hughes, 2017).   
 
2.1.2. Psychological flexibility processes  
 
Currently, there is no single measure that assessed all PF processes. Therefore, validated 






The Acceptance and Action Questionnaire (AAQ-II) measures experiential avoidance 
with good validity/reliability (Bond et al., 2011; Fledderus, Oude Voshaar, ten Klooster, & 
Bohlmeijer, 2012). Higher scores reflect greater psychological inflexibility.  
 
The Committed Action Questionnaire (CAQ-8) (McCracken, Chilcot, & Norton, 2015) has 
shown promising validity/reliability in chronic pain (McCracken et al., 2015). Higher scores 
reflect greater committed action. 
 
The Short Form Experiences Questionnaire (SF-EQ) assesses cognitive defusion and self-
as context processes with good psychometric properties in people with chronic pain 
(McCracken, Barker, & Chilcot, 2014). Higher scores indicate better cognitive defusion/self-
as-context. 
 
2.1.3. Demographic and disease variables 
 
 
Demographic and disease factors may be related to a person’s level of ART adherence 
(Carrieri et al., 2006). Age, ethnicity, gender, sexual orientation, education level, current 
employment, relationship status and time since diagnosis were included. The British 
Columbia Cognitive Complaints Inventory (BC-CCI) (Iverson & Lam, 2013) was used to rate 
perceived common cognitive impairments during the past week (Steinbrink et al., 2013). A 






2.1.4. Mood  
 
The Patient Health Questionnaire (PHQ-4) recorded self-reported symptoms of 
anxiety/depression (Kroenke, Spitzer, Williams, & Löwe, 2009) and has acceptable 




The Work and Social Adjustment Scale (WSAS) (Mundt, Marks, Shear, & Greist, 2002) 
measured everyday life interference caused by HIV. Higher scores indicate worse illness 
adjustment. The WSAS demonstrates high internal consistency (Mundt et al., 2002). 
Established cut-offs were not used because a scaling error occurred.  
 
2.2. Statistical analyses 
 
All continuous variables were checked for normality violations (George and Mallery, 
2010). The MARS-5 total score (Skewness=-3.24, SE=.17; Kurtosis=13.37, SE=.34) and 
intentional sub-scale distributions (Skewness=-3.77, SE=.15; Kurtosis=4.29, SE=.04) were 
both highly negatively skewed. Therefore, established binary cut-offs were used. Pearson’s 
correlations, t-tests and ANOVAs (and non-parametric equivalents: Cramer’s V for 
categorical variables, Pearson biserial correlations pb for continuous variables) examined 
associations or differences between the MARS-5 total and intentional/unintentional non-





Multiple binomial regressions examined relationships between PF sub-processes and 
intentional/unintentional non-adherence, after controlling for demographic and disease 
variables. Demographic and disease variables significantly related with non-adherence 
(p<.05) at the bivariate level were entered in the first step of the models. PF processes were 
entered in the following step. The proportion of explained variance was assessed using 
Nagelkerke R2 (pseudo R2). The -2 Log Likelihood statistic (-2LL) assessed model fit. Cases 
were excluded if ≥20.0% scale item data were missing. Diagnostic checks confirmed the 
validity of all regression models. Analyses were conducted using SPSS Version 24.  
 
2.3. A priori power analysis 
 
No previous studies investigated relationships between PF and self-reported adherence 
in PLWHIV. Therefore, an a priori power analysis using G*Power version 3.1.9.2. (Faul, 
Erdfelder, Lang, & Buchner, 2007) indicated a minimum of 78 participants to detect a 
medium R2 effect size of 0.15 based on studies of other psychosocial adherence correlates 
in HIV (Langebeek et al., 2014), with 80.0% power at a two-tailed α-level of .05 using a 




3.1 Demographics and adherence rates 
 
Participants (N=275) were mostly white-Caucasian (74.0%) and male (72.0%) in their late 
forties, from the UK (46.0%) and US (52.0%). The group was divided according to MARS-5 




non-adherence = <5 and intentional non-adherence = <20 on respective subscales, in line 
with other LTC samples (de Vries et al., 2014; Moon et al., 2017). Significant differences were 
found in the cognitive complaints and relationship status variables.  
 
[TABLE 1 HERE] 
 
3.2 Adherence and general functioning  
 
General functioning showed a small significant relationship with the dichotomised MARS-
5 total and intentional nonadherent subscale scores (Table 2). However, it did not correlate 
with unintentional non-adherence. Medium to large relationships between the WSAS, PF 
processes, anxiety and depression fell in expected directions. 
 
[TABLE 2 HERE] 
 
3.3 Intentional/unintentional non-adherence  
 
Variables associated with intentional non-adherence were gender (V=.177, p=.01, 
95%CI=[.06,.29], relationship status (V=.233, p=.022, 95%CI=[.16,.34]), perceived cognitive 
complaints  (rb=.25, p<.01), anxiety (rb=.223, p<.01) and depression (rb=.185, p<.01). 
Variables associated with unintentional non-adherence included years since diagnosis 
(Mnonadherent =16.75, SDnonadherent=10.65; Madherent=13.60, SDadherent=12.06, rb=-.144, p=.01) and 
perceived cognitive complaints (Table 1). These variables were entered in the first step of 





All biserial relationships between PF processes and the dichotomised adherence 
outcomes were in expected directions (Table 2). However, intentional non-adherence 
showed only a small significant association with experiential avoidance and committed 
action and was unrelated to cognitive defusion or self-as-context. Similarly, unintentional 
non-adherence was only related to committed action.  
 
The first logistic regression tested PF model components in predicting intentional non-
adherence controlling for demographic and disease variables (Table 3). Demographic and 
disease variables accounted for 19.2% (Nagelkerke R2=.192) of the variance in intentional 
non-adherence, significantly improving the model fit (2(6)=37.66, p<.01). Specifically, 
cohabitation (OR=.11, 95% CI=[.02,.49]) was associated with decreased odds of intentional 
non-adherence, and having more cognitive complaints (OR=1.10, 95% CI=[1.02,1.19]) was 
associated with increased odds of intentional non-adherence. Adding PF processes did not 
significantly improve the model fit (Δ2 (2)=1.49 (p=.47, 2LL=264.53), only explaining a 
further 0.7% (Nagelkerke ΔR2=.007) of the variance.  
 
[TABLE 3 HERE] 
 
The second logistic regression tested PF model components in predicting unintentional 
non-adherence controlling for demographic and disease variables (Table 4). Demographic 
and disease variables accounted for 11.9% (Nagelkerke R2=.119) of the variance in 
unintentional non-adherence, significantly improving the model fit (2(7)=25.39, p<.01). 
Being married or civil partnered (OR=.45, 95%CI=[.23,.86]) or widowed (OR=.16, 




Conversely, more years since diagnosis (OR=1.02., 95% CI=[1.00,1.04]) and more cognitive 
complaints (OR=1.08, 95% CI=[1.02,1.14]) were associated with increased odds of 
unintentional non-adherence. Adding committed action did not significantly improve the 
model fit (Δ2(1)=693 p=.40, 2LL=349.53, Nagelkerke ΔR2=.003). 
 






This is the first published study investigating PF processes in conjunction with 
intentional/unintentional ART non-adherence and general functioning in PLWHIV. Overall, 
small, significant bivariate relationships indicated greater PF was associated with better 
adherence. Yet, PF was not significantly associated with self-reported 
intentional/unintentional non-adherence after controlling for demographic and disease 
variables, with little difference between non-adherence-subtypes. The most potent 
predictors of non-adherence were being single, more time since diagnosis and perceived 
cognitive problems. The former emphasises the importance of contextual factors, while the 
latter is consistent with evidence showing poorer cognitive performance is associated with 
non-adherence (Lovejoy & Suhr, 2009). Similar to other psychological variables in LTCs 
(Kardas, Lewek, & Matyjaszczyk, 2013), these findings suggest PF processes have some, 
albeit limited, explanatory power in understanding ART non-adherence in PLWHIV. HIV-
specific psychological processes appear to be bigger drivers of non-adherence than general 






There are several possible reasons why PF processes showed small correlations with self-
reported non-adherence. First, self-reporting biases may have occurred and/or cut-offs used 
might not capture variability in PF, emotional or general functioning. Conversely, PF 
measures could be too ‘broad-brush’ to predict non-adherence, such that adherence 
behaviours might reflect only one among many other valued-actions. Constructing a non-
adherence-specific PF scale that is sufficiently sensitive but does not inadvertently overlap 
with adherence instruments remains challenging. Future research should use additional 
objective ART adherence measures.   
 
Second, it is plausible that participants provided an average rating over a self-selected 
timeframe on MARS-5 and PF scales, which is unspecified on both instruments. Arguably, 
retrospective bias can also arise (Moskowitz & Young, 2006). Using an adherence measure 
validated in PLWHIV with established cut-offs and a specific timeframe may help (e.g., 
(Chesney et al., 2000). Whilst further validation of the MARS-5 and its 
intentional/unintentional non-adherence cut-offs in PLWHIV is warranted, our findings 
indicate PF does not distinguish between them. One alternative might be to use objective 
momentary assessments of adherence, PF and general functioning within ecological 
momentary assessment (EMA) studies (Moitra & Gaudiano, 2016). This approach captures 
dynamic changes over time and across contexts. EMA methods also examine within-
individual and group-level relationships between variables in conjunction with relevant 
events or changes in routine (Hektner, Schmidt, & Csikszentmihalyi, 2007). 
 
The medium to large relationships observed between PF processes, general and 




& Rottenberg, 2010; Veehof, Trompetter, Bohlmeijer, & Schreurs, 2016), supporting the 
transdiagnostic applicability of PF. ACT may help PLWHIV manage distress since 
approximately 30.0% receiving ART report anxiety/depression (Lowther, Selman, Harding, & 
Higginson, 2014). Depression is a consistent predictor of ART non-adherence (Gonzalez et 
al., 2011) but this study found small/negligible relationships between self-reported non-
adherence, emotional and general functioning. This contrasts with the expectation that less 
than perfect adherence triggers low mood and reduces functioning or vice-a-versa. Perhaps 
when ART adherence is more strongly associated with mood and/or functioning, PF 
processes may play a stronger role in predicting adherence. There is an implicit assumption 
that non-adherence-related symptom deterioration equates to reduced engagement in 
valued activities. However, ACT trials in LTCs show reductions in distress, indicating that 
people can live valued lives despite the presence of difficult symptoms and prognoses 
(Graham et al., 2016), which may of course include PWLHIV making a valued-choice to not 
adhere.  
 
4.1 Limitations  
 
Causation cannot be inferred due to the cross-sectional design of the study. Additionally, 
the MARS-5 is not validated in PLWHIV and including objective biomarkers to assess 
adherence would have been preferable. Online recruitment may have introduced self-
selection bias. Indeed, over 70.0% of the sample was white and male, which is 
unrepresentative of PLWH. Furthermore, the sample was split between English-speaking UK 
and US residents. The generalisability of findings to non-Western countries requires 




PLWHIV, such as economic circumstances, stigma and lack of social support, were not 
assessed thus limiting generalisability of findings. Finally, the study did not distinguish 
between disease severity, PLWHIV and those with AIDS or different treatment regimens.  
 
4.2 Treatment Implications and Conclusions 
 
 
This evaluation did not provide evidence that the PF model is more suitable than existing 
SCMs in explaining non-adherence to ART. Therefore, ACT, which is the treatment approach 
most directly linked to increasing PF, may not be more suited to addressing non-adherence 
than existing behaviour change approaches informed by SCMs. However, this is the first 
evaluation and further research with sensitive HIV-specific proximal measurements and 
longitudinal methods may provide more clarity.  
 
Currently, studies focusing specifically on ART adherence are mostly small, uncontrolled 
and have not measured PF processes. Assessment of contextual factors alongside key 
therapeutic mechanisms in larger trials after EMA investigations will further clarify the utility 
of the PF model. Moderation analyses will help determine who may benefit and identify at 
risk groups.  
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White ethnicity (%)  82 (72.5) 122 (75.3) .15 
Employment status (%) 
Full time  























Relationship status (%) 
Single 









































Mean disease duration (SD) 13.61 (12.27) 16.57 (10.64) 
 
.039* 
Depression PHQ-4 (%) 74 (65.0) 121 (75.0) .62 
Anxiety PHQ-4 (%) 73 (65.0) 123 (76.0) .30 
Mean Cognitive Complaints 













BC-CCI (British Columbia Cognitive Complaints Inventory); PHQ-4 (Patient Health Questionnaire four 
items: screen ‘yes/caseness’ for values >3); MARS-5 (Medication Adherence Rating Scale five items: 



























anx  Unintent 
  
MARS-5 








.63** .49** -.42** -.34** .50** .44** 
BC-CCI    .48
** -.44** -.38** .47** .48** 
AAQ-II  
    
-.64** -.61** .70** .65** 
CAQ-8  
     
.63** -.57** -.56** 
SF-EQ         -.55
** -.59** 
PHQ-4 dep               .71** 
Italics = point biserial Pearson’s correlations; **Correlation is significant <.01 (2-tailed); 
*Correlation is significant <.05 (2-tailed); AAQ-II (Acceptance and Action Questionnaire II); BC-CCI 
(British Columbia Cognitive Complaints Inventory); CAQ-8 (Committed Action Questionnaire eight 
items), MARS-5 (Medication Adherence Rating Scale five items total score), MARS-5 Intent 
(Medication Adherence Rating Scale five items intentional nonadherence subscale score), MARS-
5 unintent (Medication Adherence Rating Scale five items unintentional nonadherence subscale 
score), PHQ-4 total (Patient Health Questionnaire four items), PHQ-4 dep. (Patient Health 
Questionnaire four items depression subscale), PHQ-4 anx. (Patient Health Questionnaire four 
items anxiety subscale), SF-EQ (Shortened version of the Experiences Questionnaire total score); 















Table 3 Multiple binomial logistic regression to predict intentional nonadherence (MARS-
5)  
 





2 (6) = 37.66 (p<.001) 
 
-2LL = 266.03 
  
 
b Bca 95% CI OR OR 95% CI 
     
Relationship status1     
Single vs. Married / Civil partnership -.19 -1.07, .55 .81 .38, 1.74 
Single vs. Separated or divorced .12 -1.21, 1.18 1.13 .37, 3.40 
Single vs. Cohabiting -2.20* -20.65, -1.05* .11 .02, .49 
Single vs. Widowed -.76 -20.76, .60 .46 .11, 1.85 
Single vs. Other -.72 -20.21, .43 .48 .10, 2.36 
Cognitive Complaints (BC-CCI) .10* .03, .19* 1.11 1.03, 1.19 
Depression (PHQ-4) .16 -.06, .43 1.18 .93, 1.49 
Anxiety (PHQ-4) -.01 -.26, .23 .98 .78, 1.23 
    
Step 2: Psychological flexibility processes 
   
R2=199 
 Δ2 (2) = 1.49 (p= .47) 
 




b Bca 95% CI OR OR 95% CI 
Psychological inflexibility (AAQ-II) -.01 -.07, .04 .98 .933, 1.03 
Committed action (CAQ-8) -.02 -.08, .02 .97 .931, 1.01 
     
Adherent=0, Nonadherent=1;1Single reference group=0; 2 Chi-squared goodness of fit; Δ2 (Chi-squared 
goodness of fit); b= beta value; Bca 95% bootstrapped CI  (beta value 95% confidence intervals with 1000 
samples); *beta is significant <.05 (2-tailed); OR (standardized odds ratio); OR 95% CI (standardized odds 
ratio 95% confidence intervals); -2LL(-2 Log Likelihood statistic); R2 (Nagelkerke R2 / pseudo R2); AAQ-II 
(Acceptance and Action Questionnaire II); CAQ-8 (Committed Action Questionnaire eight items) BC-CCI 






Table 4 Multiple binomial logistic regression to predict unintentional nonadherence 
(MARS-5) 
 





2 (7) = 25.39 (p<.001) 
 
-2LL = 350.22 
  
 
b Bca 95% CI OR OR 95% CI 
Relationship status1     
Single vs. Married / Civil partnership -.79* -1.50, -.16* .45 .23, .86 
Single vs. Separated or divorced -.26 -1.35, .97 .76 .27, 2.18 
Single vs. Cohabiting -.02 -.82,.82 .97 .46,2.07 
Single vs. Widowed -1.78* -3.71, -.55* .16 .04.598 
Single vs. Other -.04 -1.33, 1.39 .95 .31, 2.95 
Years since diagnosis .02* <.01, .05* 1.02 1.00,1.04 
Cognitive Complaints (BC-CCI) .07* .02,.14* 1.08 1.02, 1.14 
    
Step 2: Psychological flexibility processes 
   
R2=.122 
 Δ2 (1) = .69 (p= .40) 
 




b Bca 95% CI OR OR 95% CI 
Committed action (CAQ-8) -.01 -.04,.02 .98 .95, 1.01 
     
Adherent=0, Nonadherent=1; 1Single reference group=0; 2 Chi-squared goodness of fit; Δ2 (Chi-squared 
goodness of fit); b= beta value; Bca 95% bootstrapped CI  (beta value 95% confidence intervals with 1000 
samples); *beta is significant <.05 (2-tailed); OR (standardized odds ratio); OR 95% CI (standardized odds 
ratio 95% confidence intervals); -2LL(-2 Log Likelihood statistic); R2 (Nagelkerke R2 / pseudo R2); AAQ-II 
(Acceptance and Action Questionnaire II); CAQ-8 (Committed Action Questionnaire eight items) BC-CCI 
(British Columbia Cognitive Complaints Inventory); PHQ-4 (Patient Health Questionnaire four items). 
 
 
 
 
 
 
 
 
